Finding new treatment targets for autoimmune hormone disorders.
Official title: Identifying new immunotherapeutic targets for endocrine autoimmunity.
Funded at University of California Los Angeles · NIH-10845206 · Data updated 2026-11-12
This study is looking into how the immune system mistakenly attacks hormone-producing tissues in people with autoimmune endocrine disorders, and it aims to find new ways to treat these conditions by understanding how certain immune cells and genes work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 10, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $737,346 |
| NIH project number | 1U19AI181729-01 |
| Project ID | NIH-10845206 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with autoimmune endocrinopathies, particularly women who are disproportionately affected by these conditions.
✕Less likely to help
Patients with autoimmune conditions that do not involve endocrine tissues may not benefit from this research.
What this research studies
This research investigates autoimmune endocrinopathies, conditions where the immune system mistakenly attacks hormone-producing tissues. The project aims to understand the mechanisms behind these disorders, particularly focusing on how certain immune cells behave in these conditions. By exploring the role of specific genes and epigenetic factors, the research seeks to identify new targets for immunotherapy, which could lead to more effective treatments for patients suffering from these autoimmune diseases.
Why it matters
Potential benefit: If successful, this research could lead to new immunotherapy options for patients with autoimmune endocrinopathies, improving their treatment outcomes.
How similar studies have gone: While research on autoimmune diseases is extensive, the specific focus on immunotherapy for autoimmune endocrinopathies is relatively novel and has not been extensively tested.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Su, Maureen a — University of California Los Angeles
- Study coordinator: Su, Maureen a
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Systems genetics of vascular smooth muscle phenotypes in heart disease
Aims to understand how genetic differences influence vascular smooth muscle cells to improve prevention and treatment of coronary artery disease.
-
Motivation for Alcohol Use in Humans and How It Can Be Measured
This grant explores how people are motivated to drink alcohol and tests a safe, controlled way to study that motivation to inform better treatments for alcohol use disorder.
-
Overcoming CAR T cell resistance with tumor-targeted IL-12 to boost anti-tumor immunity
Aims to make CAR T cell therapy work better for solid tumors by using tumor-focused IL-12 to boost the body’s attack on cancer.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.